500.5

-0.66%↓

SANES

9.558

-0.95%↓

SAF

317.6

+1.02%↑

BBVA

18.375

-0.62%↓

BNP

86.24

-0.67%↓

500.5

-0.66%↓

SANES

9.558

-0.95%↓

SAF

317.6

+1.02%↑

BBVA

18.375

-0.62%↓

BNP

86.24

-0.67%↓

500.5

-0.66%↓

SANES

9.558

-0.95%↓

SAF

317.6

+1.02%↑

BBVA

18.375

-0.62%↓

BNP

86.24

-0.67%↓

500.5

-0.66%↓

SANES

9.558

-0.95%↓

SAF

317.6

+1.02%↑

BBVA

18.375

-0.62%↓

BNP

86.24

-0.67%↓

500.5

-0.66%↓

SANES

9.558

-0.95%↓

SAF

317.6

+1.02%↑

BBVA

18.375

-0.62%↓

BNP

86.24

-0.67%↓

Inicio・Lista de Acciones・DBV Technologies SA

D
DBV Technologies SA

Cerrado

3.805 1.87

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

3.555

Máximo

3.895

Métricas clave
By Trading Economics
Ingresos	8.7M -33M
BPA	-0.1
Margen de beneficio	-1,888.814
Empleados	117
EBITDA	7.5M -31M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 meses	+47.85% upside

Dividendos
By Dow Jones
Próximas Ganancias	10 abr 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	-15M 421M
Apertura anterior	1.94
Cierre anterior	3.805

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

1.61 / 1.72 Soporte y Resistencia

DBV Technologies SA Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

6 mar 2026, 19:32 UTC

Adquisiciones, fusiones, absorciones

Diana Shipping Increases Offer to Acquire Genco -- Update

6 mar 2026, 17:44 UTC

Adquisiciones, fusiones, absorciones

Lonza to Offload Majority Stake in Capsule Business to Lone Star in $2.2 Billion Deal

6 mar 2026, 22:26 UTC

Noticias de Eventos Importantes

Why $100 Oil Is Now in Sight. Who Wins, Who Loses. -- Barrons.com

6 mar 2026, 22:07 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Boeing Says Spirit Acquisition Will Help Improve Safety -- Market Talk

6 mar 2026, 22:03 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

6 mar 2026, 22:03 UTC

Charlas de Mercado

Boeing CEO's Pay Nears $24 Million During Recovery Phase -- Market Talk

6 mar 2026, 21:50 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Financial Services Roundup: Market Talk

6 mar 2026, 21:37 UTC

Ganancias

Salesforce Stock Might Not Be an AI Loser After All -- Barrons.com

6 mar 2026, 21:25 UTC

Noticias de Eventos Importantes

How The Iran War Impacts Ukraine. -- Barrons.com

6 mar 2026, 21:17 UTC

Ganancias

Burlington Stores' Strong Year Should Lift the Stock. What Comes Next. -- Barrons.com

6 mar 2026, 20:50 UTC

Ganancias

Marvell Stock Pops 20%. Semiconductor Earnings Show AI Demand Is Strong. -- Barrons.com

6 mar 2026, 20:46 UTC

Ganancias

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

6 mar 2026, 20:31 UTC

Noticias de Eventos Importantes

Oil Prices Soar Past $90. Trump Demands 'Unconditional Surrender' From Iran -- and Kuwait Cut Production. -- Barrons.com

6 mar 2026, 20:18 UTC

Charlas de Mercado

Oil Makes Record Weekly Gains As Strait of Hormuz Stays Shut -- Market Talk

6 mar 2026, 20:12 UTC

Charlas de Mercado

Noticias de Eventos Importantes

U.S. Natural Gas Futures Gain on Global Energy Turmoil -- Market Talk

6 mar 2026, 19:10 UTC

Charlas de Mercado

Noticias de Eventos Importantes

$150 Oil Seen As Realistic If Hormuz Closure Lasts -- Market Talk

6 mar 2026, 18:54 UTC

Charlas de Mercado

Fed's Hammack: Dollar Hasn't Lost Prime Status -- Market Talk

6 mar 2026, 18:44 UTC

Charlas de Mercado

Noticias de Eventos Importantes

U.S. Oil Rig Count Increases By 4 to 411 -- Market Talk

6 mar 2026, 18:08 UTC

Ganancias

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

6 mar 2026, 18:04 UTC

Ganancias

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

6 mar 2026, 18:04 UTC

Ganancias

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

6 mar 2026, 17:49 UTC

Charlas de Mercado

AI-Driven Picks-And-Shovels Bet Comes With Risks -- Market Talk

6 mar 2026, 17:46 UTC

Noticias de Eventos Importantes

Kuwait Cuts Oil Production as Fallout From Iran Conflict Intensifies -- Update

6 mar 2026, 17:40 UTC

Charlas de Mercado

Ganancias

Marvell's Long-Term Outlook Well-Received By Investors -- Market Talk

6 mar 2026, 17:40 UTC

Ganancias

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

6 mar 2026, 17:32 UTC

Charlas de Mercado

Noticias de Eventos Importantes

No Quick Solution for Hormuz Shipping as U.S. Oil Tops $90 -- Market Talk

6 mar 2026, 17:28 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Aluminum Rising as Strait of Hormuz Stays Locked -- Market Talk

6 mar 2026, 17:20 UTC

Charlas de Mercado

Ganancias

Auto & Transport Roundup: Market Talk

6 mar 2026, 17:20 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

6 mar 2026, 17:20 UTC

Adquisiciones, fusiones, absorciones

BlackRock Sticks to Redemption Minimum on Credit Fund, Sends Shares Lower -- WSJ

Comparación entre iguales

Cambio de precio

DBV Technologies SA Esperado

Precio Objetivo

By TipRanks

47.85% repunte

Estimación a 12 meses

Media 5.5 EUR 47.85%

Máximo 5.5 EUR

Mínimo 5.5 EUR

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para DBV Technologies SA Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

1 ratings

Comprar

Mantener

Vender

De acuerdo con 1 analistas que ofrecen calificaciones bursátiles a para DBV Technologies SA Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

1.61 / 1.72Soporte y Resistencia

Recent bearish events outweigh bullish events.

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de DBV Technologies SA

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs includes vaccine for the respiratory syncytial virus, potential treatments for inflammatory bowel disease, celiac disease, and type I diabetes. In addition, it develops Viaskin technology platform, a platform to potentially treat food allergy. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.